IRLAB Therapeutics AB banner

IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 1.55 SEK 1.71%
Market Cap: kr131.5m

IRLAB Therapeutics AB
Investor Relations

IRLAB Therapeutics AB engages in the provision of novel treatments for disorders of the brain that focuses on illness in the central nervous system. The company is headquartered in Goeteborg, Vastra Gotalands. The company went IPO on 2017-02-28. The company focuses on illnesses in the central nervous system and primarily on development of drugs to assist patients with Parkinson’s disease. The firm possesses a research platform Integrative Screening Process (ISP), which aims to discover and develop drug candidates for the treatment of brain diseases. The firm operates projects on both clinical phase and preclinical phases. The primary projects are IRL790 and IRL752, both on clinical phase. The IRL790 project is a psychomotor stabilizer for the treatment of levodopa (L-dopa) amino acid that dyskinesia induces in Parkinson’s Disease (PD-LIDs) and Parkinson Disease psychosis (PD-Psychosis). The IRL752 project aims at cortical enhancement for the treatment of Parkinson Disease Dementia (PD-D) and Behavioral and Psychological Symptoms of Dementia (BPSD).

Show more
Loading
IRLAB A
OMX Stockholm 30
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2024
Call Date
Oct 30, 2024
Q3 2024 Earnings Call
No Analysis Available

This earnings call has not been analyzed yet.

If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.

Request Earnings Call Analysis
Other Earnings Calls

Management

Dr. Kristina Torfgard Ph.D.
Chief Executive Officer
No Bio Available
Mr. Viktor Siewertz
Chief Financial Officer
No Bio Available
Dr. Clas Sonesson Ph.D.
Chief Scientific Officer
No Bio Available
Dr. Peder Svensson Ph.D.
Chief Information Officer and Director of Computational Chemistry & Biology
No Bio Available
Ms. Tove Bergenholt
Global IR & Communications
No Bio Available
Ms. Cecilia Tivert Stenberg B.Sc, B.Sc.
Head of Finance & Human Resource and Director of Accounting & Human Resources
No Bio Available
Dr. Nicholas Waters Ph.D.
Executive VP and Head of R&D
No Bio Available
Dr. Joakim Tedroff M.D., Ph.D.
Chief Medical Officer
No Bio Available

Contacts

Address
VASTRA GOTALANDS
Goeteborg
Arvid Wallgrens Backe 20
Contacts
+46317573800
www.irlab.se
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett